{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Substances humiques : Questions médicales les plus fréquentes",
"headline": "Substances humiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Substances humiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-25",
"dateModified": "2025-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Substances humiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mélanges complexes",
"url": "https://questionsmedicales.fr/mesh/D045424",
"about": {
"@type": "MedicalCondition",
"name": "Mélanges complexes",
"code": {
"@type": "MedicalCode",
"code": "D045424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Substances humiques",
"alternateName": "Humic Substances",
"code": {
"@type": "MedicalCode",
"code": "D006812",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fan Yang",
"url": "https://questionsmedicales.fr/author/Fan%20Yang",
"affiliation": {
"@type": "Organization",
"name": "School of Water Conservancy and Civil Engineering, Northeast Agricultural University, Harbin 150030, China; Joint Laboratory of Northeast Agricultural University and Max Planck Institute of Colloids and Interfaces (NEAU-MPICI), Harbin 150030, China. Electronic address: yangfan_neau@163.com."
}
},
{
"@type": "Person",
"name": "Irina V Perminova",
"url": "https://questionsmedicales.fr/author/Irina%20V%20Perminova",
"affiliation": {
"@type": "Organization",
"name": "Lomonosov Moscow State University, 119991, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Kui Cheng",
"url": "https://questionsmedicales.fr/author/Kui%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Northeast Agricultural University and Max Planck Institute of Colloids and Interfaces (NEAU-MPICI), Harbin 150030, China; College of Engineering, Northeast Agricultural University, Harbin 150030, China."
}
},
{
"@type": "Person",
"name": "Andrey I Konstantinov",
"url": "https://questionsmedicales.fr/author/Andrey%20I%20Konstantinov",
"affiliation": {
"@type": "Organization",
"name": "Lomonosov Moscow State University, 119991, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Chunyu Tang",
"url": "https://questionsmedicales.fr/author/Chunyu%20Tang",
"affiliation": {
"@type": "Organization",
"name": "Joint laboratory of Northeast Agricultural University and Max Planck Institute of Colloids and Interfaces (NEAU-MPICI), Harbin 150030, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Different Prostatic Tissue Microbiomes between High- and Low-Grade Prostate Cancer Pathogenesis.",
"datePublished": "2024-08-16",
"url": "https://questionsmedicales.fr/article/39201629",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25168943"
}
},
{
"@type": "ScholarlyArticle",
"name": "Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38682731",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/sju.v59.34015"
}
},
{
"@type": "ScholarlyArticle",
"name": "5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37061671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12894-023-01235-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35716730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humpath.2022.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Detection rate and variables associated with incidental prostate cancer by holmium laser enucleation of the prostate.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35584916",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/iju.14917"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Substances humiques",
"item": "https://questionsmedicales.fr/mesh/D006812"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Substances humiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Substances humiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Substances humiques",
"description": "Comment diagnostiquer une carence en substances humiques ?\nQuels tests sont utilisés pour mesurer les substances humiques ?\nLes substances humiques peuvent-elles être mesurées dans le sang ?\nQuels indicateurs de santé des sols sont liés aux substances humiques ?\nComment évaluer l'impact des substances humiques sur la santé des plantes ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Substances humiques",
"description": "Quels symptômes indiquent un manque de substances humiques dans le sol ?\nLes substances humiques affectent-elles la qualité de l'eau ?\nComment les substances humiques influencent-elles la santé des sols ?\nQuels effets les substances humiques ont-elles sur les cultures ?\nLes substances humiques peuvent-elles causer des symptômes chez l'homme ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Substances humiques",
"description": "Comment prévenir la dégradation des substances humiques dans le sol ?\nQuelles pratiques agricoles favorisent les substances humiques ?\nComment la gestion de l'eau influence-t-elle les substances humiques ?\nLes substances humiques peuvent-elles être protégées par des pratiques de conservation ?\nQuel rôle joue la biodiversité dans la préservation des substances humiques ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Substances humiques",
"description": "Comment améliorer la teneur en substances humiques du sol ?\nQuels produits contiennent des substances humiques ?\nLes substances humiques peuvent-elles être utilisées en agriculture ?\nComment les substances humiques aident-elles à traiter les sols pollués ?\nLes substances humiques sont-elles utilisées en médecine ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Substances humiques",
"description": "Quelles complications peuvent survenir avec une carence en substances humiques ?\nLes substances humiques peuvent-elles interagir avec des polluants ?\nComment une mauvaise gestion des substances humiques affecte-t-elle l'environnement ?\nLes substances humiques peuvent-elles causer des problèmes de santé ?\nQuels effets les substances humiques ont-elles sur les écosystèmes aquatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Substances humiques",
"description": "Quels facteurs augmentent la dégradation des substances humiques ?\nComment le changement climatique affecte-t-il les substances humiques ?\nQuels types de sols sont plus susceptibles de perdre des substances humiques ?\nL'utilisation de pesticides influence-t-elle les substances humiques ?\nQuels impacts des pratiques agricoles intensives sur les substances humiques ?",
"url": "https://questionsmedicales.fr/mesh/D006812?mesh_terms=Prostatic+Neoplasms&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en substances humiques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse des sols et des échantillons d'eau pour évaluer leur teneur en humiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les substances humiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests chimiques et spectroscopiques, comme la spectroscopie UV-Vis, sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles être mesurées dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont principalement présentes dans le sol et l'eau, pas dans le sang humain."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé des sols sont liés aux substances humiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biodiversité microbienne et la capacité de rétention d'eau sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des substances humiques sur la santé des plantes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "On évalue la croissance des plantes et leur résistance aux maladies en fonction de leur teneur en humiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un manque de substances humiques dans le sol ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes incluent une croissance réduite des plantes et une mauvaise rétention d'eau."
}
},
{
"@type": "Question",
"name": "Les substances humiques affectent-elles la qualité de l'eau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles améliorent la qualité de l'eau en réduisant la toxicité et en favorisant la filtration."
}
},
{
"@type": "Question",
"name": "Comment les substances humiques influencent-elles la santé des sols ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles améliorent la structure du sol, augmentent la fertilité et favorisent la biodiversité."
}
},
{
"@type": "Question",
"name": "Quels effets les substances humiques ont-elles sur les cultures ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent le rendement des cultures et améliorent leur résistance aux stress environnementaux."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles causer des symptômes chez l'homme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles ne sont pas toxiques pour l'homme et n'entraînent pas de symptômes directs."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dégradation des substances humiques dans le sol ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une agriculture durable et éviter l'érosion du sol aide à préserver les humiques."
}
},
{
"@type": "Question",
"name": "Quelles pratiques agricoles favorisent les substances humiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rotation des cultures et l'utilisation de cultures de couverture favorisent leur accumulation."
}
},
{
"@type": "Question",
"name": "Comment la gestion de l'eau influence-t-elle les substances humiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion adéquate de l'eau prévient le lessivage des humiques et maintient leur concentration."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles être protégées par des pratiques de conservation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les pratiques de conservation comme le paillage aident à maintenir leur niveau dans le sol."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biodiversité dans la préservation des substances humiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biodiversité riche favorise la décomposition et la formation de substances humiques dans le sol."
}
},
{
"@type": "Question",
"name": "Comment améliorer la teneur en substances humiques du sol ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ajout de compost, de fumier ou d'amendements organiques enrichit le sol en humiques."
}
},
{
"@type": "Question",
"name": "Quels produits contiennent des substances humiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des extraits de tourbe, de lignite et des produits à base de compost en contiennent."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles être utilisées en agriculture ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont utilisées comme amendements pour améliorer la fertilité et la structure du sol."
}
},
{
"@type": "Question",
"name": "Comment les substances humiques aident-elles à traiter les sols pollués ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent immobiliser les contaminants et améliorer la dégradation des polluants."
}
},
{
"@type": "Question",
"name": "Les substances humiques sont-elles utilisées en médecine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont explorées pour leurs propriétés antioxydantes et anti-inflammatoires, mais pas encore validées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en substances humiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence peut entraîner une baisse de la fertilité du sol et des rendements agricoles."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles interagir avec des polluants ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent se lier à des polluants, réduisant leur biodisponibilité et leur toxicité."
}
},
{
"@type": "Question",
"name": "Comment une mauvaise gestion des substances humiques affecte-t-elle l'environnement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une dégradation des sols, une perte de biodiversité et une pollution de l'eau."
}
},
{
"@type": "Question",
"name": "Les substances humiques peuvent-elles causer des problèmes de santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles ne sont pas considérées comme nocives pour la santé humaine lorsqu'elles sont utilisées correctement."
}
},
{
"@type": "Question",
"name": "Quels effets les substances humiques ont-elles sur les écosystèmes aquatiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent améliorer la qualité de l'eau et soutenir la vie aquatique en réduisant la toxicité."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la dégradation des substances humiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'érosion, la surexploitation des sols et l'utilisation excessive de produits chimiques sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment le changement climatique affecte-t-il les substances humiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le changement climatique peut modifier la décomposition de la matière organique, affectant les humiques."
}
},
{
"@type": "Question",
"name": "Quels types de sols sont plus susceptibles de perdre des substances humiques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les sols sableux et ceux soumis à une forte érosion sont plus susceptibles de perdre des humiques."
}
},
{
"@type": "Question",
"name": "L'utilisation de pesticides influence-t-elle les substances humiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation excessive de pesticides peut nuire à la biodiversité et réduire les humiques."
}
},
{
"@type": "Question",
"name": "Quels impacts des pratiques agricoles intensives sur les substances humiques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles entraînent une dégradation du sol et une diminution des substances humiques, affectant la fertilité."
}
}
]
}
]
}
Numerous human pathologies, such as neoplasia, are related to particular bacteria and changes in microbiome constituents. To investigate the association between an imbalance of bacteria and prostate c...
Changes in work-up and histopathological assessment have caused stage and grade migration in men with prostate cancer (PCa). The aim of this study was to assess temporal trends in risk of PCa death fo...
Men aged 75 or younger with Charlson Comorbidity index 0-1 diagnosed with favourable-risk PCa (T1-T2, prostate specific antigen [PSA] <20 ng/mL and Gleason score 6 or 7[3+4]) in the period 2000-2016 w...
A total of 9,666 men were selected for each treatment strategy. The 7-year cumulative incidence of PCa death decreased in all risk and treatment groups. For example, the incidence in men diagnosed wit...
Men diagnosed in 2011-2016 with low-risk and favourable intermediate-risk PCa have a similar relative benefit but smaller absolute benefit of curative treatment compared to men diagnosed in 2000-2005....
Magnetic resonance imaging (MRI) scans are increasingly first-line investigations for suspected prostate cancer, and essential in the decision for biopsy. 5-alpha reductase inhibitor (5-ARI) use has b...
From 2015 to 2020, we collected retrospective data of consecutive patients undergoing prostate biopsy at one centre. We included patients who were biopsy-naïve, had prior negative biopsies, or on acti...
351 men underwent saturation biopsy with or without targeted biopsies. 54 (15.3%) had a history of 5-ARI use. On mpMRI, there was no significant difference between the 5ARI and non-5-ARI groups in PIR...
Our study found significant differences in biochemical, imaging and biopsy characteristics between 5-ARI and non-5-ARI groups. While both groups had similar PIRADS distribution, 5-ARI patients had a l...
A wide range of treatment options are available to patients with prostate cancer. Some treatments are standard (currently used) while some are emerging therapies. Androgen deprivation therapy is typic...
Holmium laser enucleation of the prostate is well-established and effective for bladder outlet obstruction due to benign prostatic hyperplasia. The objective of this study was to examine the detection...
A total of 612 patients were enrolled. We retrospectively examined the detection rate of incidental prostate cancer and perioperative variables associated with them....
Forty-nine of 612 patients were diagnosed with incidental prostate cancer. Univariate logistic regression analysis showed that higher prostate-specific antigen density (odds ratio 3.34, 95% confidence...
The detection rate of incidental prostate cancer was 8.0%, and findings of the prostate cancer on magnetic resonance imaging were an independent predictive factor for incidental prostate cancer....
Prostate cancer (PCa) is highly heritable. No validated PCa risk model currently exists. We therefore sought to develop a genetic risk model that can provide personalized predicted PCa risks on the ba...
We developed a risk model using a kin-cohort comprising individuals from 16,633 PCa families ascertained in the United Kingdom from 1993 to 2017 from the UK Genetic Prostate Cancer Study, and complex ...
The most parsimonious model included the effects of pathogenic variants in...
To our knowledge, this is the first validated risk model offering personalized PCa risks. The model will assist in counseling men concerned about their risk and can facilitate future risk-stratified p...
Reducing low-value clinical care is an important strategy to mitigate environmental pollution caused by health care....
To estimate the environmental impacts associated with prostate magnetic resonance imaging (MRI) and prostate biopsy....
We performed a cradle-to-grave life cycle assessment of prostate biopsy. Data included materials and energy inventory, patient and staff travel contributed by prostate MRI, transrectal ultrasound guid...
Greenhouse gas emissions (CO...
In the USA, a single transrectal prostate biopsy procedure including prostate MRI, and targeted and systematic biopsies emits an estimated 80.7 kg CO...
A prostate biopsy contributes a calculable environmental footprint. Modifying or reducing the number of biopsies performed through existing evidence-based approaches would decrease health care polluti...
We estimated that prostate magnetic resonance imaging (MRI) with a prostate biopsy procedure emits the equivalent of 80.7 kg of carbon dioxide. Performing fewer unnecessary prostate biopsies or using ...
A family history (FH) of prostate cancer (PrCa) is associated with an increased likelihood of PrCa diagnosis. Conflicting evidence exists regarding familial PrCa and clinical outcomes among PrCa patie...
To determine how the number, degree, and age of a PrCa patient's affected relatives are associated with OS and PCSS of those already diagnosed with PrCa....
The UK Genetic Prostate Cancer Study is a longitudinal, multi-institutional, observational study collecting baseline and follow-up clinical data since 1992. We examined OS and PCSS in 16340 men by deg...
The primary outcome was all-cause mortality among PrCa patients. The risk of death with respect to FH was assessed by calculating hazard ratios from Cox proportional hazard regression models, adjustin...
A stronger FH was inversely associated with the risk of all-cause and PrCa-specific mortality. This association was greater in those with an increasing number (p-trend < 0.001) and increasing closenes...
Based on the investigation of the type and timing of relatives' cancers, it is likely that reductions in mortality are due almost completely to a greater awareness of the disease. This study provides ...
We were interested in how a family history of prostate cancer affects survival in prostate cancer patients. We studied 16340 patients, categorised them according to the strength of their family histor...
Assess radiologists' contribution to variation in clinically significant prostate cancer (csPCa) detection in patients with elevated prostate-specific antigen (PSA) and multiparametric MRI (mpMRI)....
This institutional review board-approved, retrospective cohort study was performed at a tertiary, academic, National Cancer Institute-designated Comprehensive Cancer Center with a multidisciplinary pr...
Study cohort included 960 MRIs in 928 men, mean age 64.0 years (SD ± 7.4), and 59.8% (555 of 928) had csPCa. Interpreting radiologist was not significant individually (P > .999) or combined with mpMRI...
Although there is known in-practice variation in radiologists' interpretation of mpMRI, in our multidisciplinary prostate cancer program we found no significant radiologist-attributable variation in c...
Recent data have found an overall survival benefit from prostate-directed radiotherapy in patients with low-volume metastatic prostate cancer. Prostate SBRT is an attractive treatment in this setting ...
We reviewed patients with low-volume metastatic disease who received prostate SMART from October 2019 to December 2021 on a 0.35T MR-Linac. The cohort included 14 patients. Genitourinary (GU) and gast...
The median follow-up time was 29 months. Seven patients had hormone sensitive prostate cancer and 7 had castrate resistant prostate cancer (CRPC). 13 patients received 36.25 Gy in 5 fractions and one ...
Prostate SMART was found to be well tolerated and all patients had local control of disease within the prostate at the time of last follow-up. Prostate SMART may represent a low-risk and well-tolerate...
